CBP China Botanic Pharmaceutical Inc.

HARBIN, China, Sept. 19, 2012 /PRNewswire/ -- China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines ("TCM") in China, today announced that the Company will host a conference call at 9:00 a.m. Eastern Time on Thursday, September 20, 2012 to discuss financial results for the third quarter of fiscal year 2012, ended July 31, 2012.

Joining Mr. Shaoming Li, China Botanic's Chairman and CEO, will be Mr. Guangtao Li, the Company's Vice President and Mr. David Dong, the Company's CFO.

To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-394-2209. International callers should dial 706-758-1481. The conference ID number for the call is 28057322.

If you are unable to participate in the call at this time, a replay will be available on Thursday, September 20, 2012 at 12:00 noon Eastern Time, through Monday, October 1, 2012. To access the replay, dial 855-859-2056. International callers should dial 404-537-3406. The conference ID number for the replay is 28057322.

About China Botanic Pharmaceutical Inc.

China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China. For more information, please visit www.renhuang.com.

SOURCE China Botanic Pharmaceutical Inc.